Sign In
Buy ME
$0.606
+0 (+0%)
At Close: Sep 16, 2025
23andMe cuts 40% of staff in restructuring
05:51pm, Tuesday, 12'th Nov 2024
23andMe announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. The genetic testing company is also discontinuing its th
What's happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA testing company
05:01pm, Tuesday, 12'th Nov 2024
DNA-testing company 23andMe (Nasdaq: ME), once an industry leader that attracted millions of customers, including rapper Snoop Dogg and investor Warren Buffett, has announced significant cuts to its o
23andMe reports sales decline day after announcing plans to cut 40% of workforce
12:52pm, Tuesday, 12'th Nov 2024
23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The embattled genetic testing company said Monday that it's cutting about 200 jobs, or ab
23andMe's stock turns lower after company posts its latest quarterly loss
08:05am, Tuesday, 12'th Nov 2024
Stock had gained late Monday on news it would cut 40% of its workforce as part of a restructuring.
23andMe to cut 40% of its workforce as it looks to stablise the business
04:10am, Tuesday, 12'th Nov 2024
Genetic testing firm 23andMe announced plans to cut 40% of its workforce, or around 200 jobs, as part of a cost-saving effort aimed at stabilising the company. It will also halt work on its therapy de
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
10:20pm, Monday, 11'th Nov 2024
The genetics company is closing a unit that was once seen as core to its future.
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
07:40pm, Monday, 11'th Nov 2024
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.
23andMe cuts 40% of its workforce
05:42pm, Monday, 11'th Nov 2024
Genetic testing firm 23andMe said on Monday it is reducing its overall headcount by over 200 employees or about 40% of the workforce, as part of a restructuring program.
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
05:30pm, Monday, 11'th Nov 2024
Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences strategic alternatives process for all in-hou
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
05:54pm, Thursday, 07'th Nov 2024
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- An earlier release under the same headline should have noted 23andMe Holding Co. (Nasdaq: ME) (23andMe) will report financial results for the secon
23andMe to Report Q2 FY2025 Financial Results
07:30am, Thursday, 07'th Nov 2024
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report financial r
23andMe Regains Compliance With Nasdaq Listing Requirements
05:00pm, Wednesday, 30'th Oct 2024
SUNNYVALE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced that
23andMe appoints new board members as it works to stem the company's slide
04:52pm, Wednesday, 30'th Oct 2024
23andMe said it appointed three new independent directors to its board on Monday. All seven of 23andMe's previous directors resigned in September over its "strategic direction.
23andMe appoints three new board members following abrupt resignations
11:54am, Tuesday, 29'th Oct 2024
23andMe appointed three new independent directors to its board, the company said Tuesday. The announcement comes about a month after all seven of 23andMe's previous independent directors abruptly resi
23andMe Appoints Three New Independent Directors to Board
07:30am, Tuesday, 29'th Oct 2024
SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced the
